Amplyfy marks fifth year at Meghan Rose Bradley Foundation gala

Amplyfy, Inc attended the Meghan Rose Bradley Foundation’s annual gala for the fifth straight year, underscoring its support for pediatric brain cancer research and awareness. The event brought together families, community members and supporters as the foundation continues funding research and advocacy efforts.

Why it matters: - Amplyfy, Inc’s recurring presence at the Meghan Rose Bradley Foundation gala signals sustained private support for pediatric brain cancer research. - The foundation focuses on awareness, advocacy and research funding for a disease that affects thousands of children each year. - Community backing helps support research that could improve treatment options and outcomes for children and families facing brain cancer.

What happened: - Amplyfy, Inc team members attended the Meghan Rose Bradley Foundation’s annual gala in support of the organization’s mission. - The company said it attended the gala for the fifth year in a row. - The event brought together families, community members and supporters to honor Meghan Rose Bradley’s legacy. - The article was published Sept. 29, 2026.

The details: - The Meghan Rose Bradley Foundation was established in December 2004 in memory of Meghan Bradley, who died of brain cancer in November 2004. - The foundation works to increase public awareness of pediatric brain cancer through education and advocacy. - The foundation also raises funds for research aimed at improving treatment and saving children’s lives. - Foundation-published information says about 3,140 children under age 20 are diagnosed with primary brain tumors each year. - That estimate includes about 2,000 children ages 16 and under. - The foundation says researchers continue to study possible genetic and environmental factors linked to these tumors. - The foundation currently supports research led by Dr. Ulrike Gerdemann at Boston Children’s Hospital. - The research aims to improve immunotherapy for brain cancer. - The work examines why certain brain cancers evade killer T cells and how existing immunotherapies might be modified to work against a broader range of brain cancers. - Amplyfy, Inc Regional Manager Andrew K said the event was meaningful to the team because it brings people together around an important cause. - Andrew K said the company has built a strong relationship with the foundation’s founders. - Andrew K said the work to increase awareness and support research gives hope to children and families facing pediatric brain cancer.

Between the lines: - Amplyfy, Inc is using local philanthropy to reinforce its community presence beyond its marketing and sales work. - The foundation’s annual gala appears to function as both a fundraiser and a relationship-building event for long-term supporters. - The emphasis on immunotherapy suggests the foundation is backing research with the potential to affect future treatment approaches, not just awareness efforts.

What’s next: - Amplyfy, Inc said it looks forward to continuing to participate in community initiatives and meaningful causes. - The Meghan Rose Bradley Foundation said it will continue combining education, advocacy, community support and research funding to advance its mission. - The foundation will keep using events such as its annual gala to bring supporters together and maintain momentum for pediatric brain cancer research.

The bottom line: - Amplyfy, Inc’s fifth consecutive gala appearance shows a sustained corporate commitment to a local foundation focused on pediatric brain cancer research and support.